PHYTOBIOTICS NORDIC ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Bankruptcy risk for industry  2.3% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 15.1% 14.0% 10.1% 25.4%  
Credit score (0-100)  0 16 18 26 3  
Credit rating  N/A BB BB BB B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12

Net sales  0 0 0 0 0  
Gross profit  0.0 868 877 894 -39.8  
EBITDA  0.0 58.2 87.4 168 -42.0  
EBIT  0.0 58.2 87.4 168 -42.0  
Pre-tax profit (PTP)  0.0 55.8 84.9 164.9 -47.8  
Net earnings  0.0 42.8 64.8 128.0 -47.8  
Pre-tax profit without non-rec. items  0.0 55.8 84.9 165 -47.8  

 
See the entire income statement

Balance sheet (kDKK) 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 143 208 336 288  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 344 423 514 315  

Net Debt  0.0 -192 -167 -36.4 -83.7  
 
See the entire balance sheet

Volume 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 868 877 894 -39.8  
Gross profit growth  0.0% 0.0% 1.0% 1.9% 0.0%  
Employees  0 1 1 1 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% -100.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 344 423 514 315  
Balance sheet change%  0.0% 0.0% 22.8% 21.7% -38.7%  
Added value  0.0 58.2 87.4 167.7 -42.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 3.0 -1.0  

Profitability 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 6.7% 10.0% 18.8% 105.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 16.9% 22.8% 35.8% -10.1%  
ROI %  0.0% 40.7% 49.8% 61.7% -13.5%  
ROE %  0.0% 29.9% 36.9% 47.1% -15.3%  

Solidity 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Equity ratio %  0.0% 41.5% 49.1% 65.2% 91.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -330.1% -191.5% -21.7% 199.5%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Quick Ratio  0.0 1.7 2.0 2.9 11.5  
Current Ratio  0.0 1.7 2.0 2.9 11.5  
Cash and cash equivalent  0.0 192.0 167.3 36.4 83.7  

Capital use efficiency 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 142.9 207.7 335.6 287.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 58 87 168 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 58 87 168 0  
EBIT / employee  0 58 87 168 0  
Net earnings / employee  0 43 65 128 0